About
In her research, Dr. Harhay focuses on the impacts of typically unmeasured risk factors, such as physical function, cognitive impairment and body composition on the health outcomes of people with kidney disease. Her research has also examined how health policy influences access to care for people with kidney disease. In addition, Dr. Harhay is actively engaged in translational research to develop novel biomedical tools to improve outcomes in kidney disease and transplantation. Dr. Harhay is currently the principal investigator of two grants from the National Institutes of Health ([NIH] K23DK105207, "Patterns and Implications of Functional Decline Among Kidney Transplant Candidates" and R01DK124388, “Identifying Healthy and High-Risk Weight Loss Phenotypes to Optimize Obesity Management in End-Stage Kidney Disease”) and a Commonwealth Universal Research Enhancement (CURE) grant entitled "Implications of Unstable Cerebral Oxygenation on the Safety and Tolerability of Hemodialysis." She was also awarded a Coulter-Drexel Translational Research Partnership program grant with Dr. Yury Gogotsi (principal investigator) to develop a dialysis application for MXenes, a nanomaterial discovered at Drexel University. She is also the Drexel University site principal investigator of two NIH-funded, multi-center kidney transplant studies.
Prior to coming to Drexel University, Dr. Harhay served as an instructor of medicine at the University of Pennsylvania, during which time she was awarded a NIDDK Ruth L. Kirschstein National Research Service Award (F32) for a grant entitled "Rehospitalization After Renal Transplant: Patterns, Predictors & Implications"